This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Study of Eyes and Attention Deficit (SEAD)

This study has been completed.
Information provided by:
Ohio State University Identifier:
First received: May 9, 2007
Last updated: July 1, 2008
Last verified: July 2008
Attention-Deficit Hyperactivity Disorder (ADHD) is considered to be one of the most prevalent chronic health conditions in children. It affects between 4% and 12% of young children. A relationship between convergence insufficiency (eye teaming) and ADHD has been shown. However, the effect of ADHD medications on focusing and eye teaming has not been previously investigated. Therefore, the purpose of this study is to determine the effect of ADHD medication on focusing and eye teaming skills.

ADHD Convergence Insufficiency Accommodative Insufficiency

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Ohio State University:

Estimated Enrollment: 75

Ages Eligible for Study:   7 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Best corrected visual acuity of 20/25 in both eyes at distance and near;
  • Willingness to wear eyeglasses or contact lenses to correct refractive error, if necessary;
  • 500" random dot stereopsis

Exclusion Criteria:

  • Amblyopia (lazy eye);
  • Eye disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00472511

Sponsors and Collaborators
Ohio State University
Principal Investigator: Levelle Jenkins, OD Ohio State University
Principal Investigator: Marjean Kulp, OD, MS Ohio State University
  More Information Identifier: NCT00472511     History of Changes
Other Study ID Numbers: 2001H0269
Study First Received: May 9, 2007
Last Updated: July 1, 2008

Additional relevant MeSH terms:
Ocular Motility Disorders
Central Nervous System Diseases
Nervous System Diseases
Cranial Nerve Diseases
Eye Diseases processed this record on September 19, 2017